within Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A10A_InsulinsAndAnalogues.A10AE07_InsulinIcodec;

model InsulinIcodec
  extends Pharmacolibrary.Drugs.ATC.A.A10AE07;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>A10AE07</td></tr><td>route:</td><td>subcutaneous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Insulin icodec is a long-acting, once-weekly basal insulin analogue developed for the treatment of diabetes mellitus in adults. Its ultra-long action profile allows for stable and sustained glucose-lowering effects, providing an alternative to daily basal insulins. It is approved for medical use in the European Union.</p><h4>Pharmacokinetics</h4><p>Population pharmacokinetic parameters reported for adult subjects with type 2 diabetes mellitus, both male and female, following subcutaneous administration.</p><h4>References</h4><ol><li><p>Nishimura, E, et al., &amp; Haahr, H (2021). Molecular and pharmacological characterization of insulin icodec: a new basal insulin analog designed for once-weekly dosing. <i>BMJ open diabetes research &amp; care</i> 9(1) –. DOI:<a href=&quot;https://doi.org/10.1136/bmjdrc-2021-002301&quot;>10.1136/bmjdrc-2021-002301</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/34413118/&quot;>https://pubmed.ncbi.nlm.nih.gov/34413118</a></p></li><li><p>Pieber, TR, et al., &amp; Haahr, H (2023). Pharmacokinetic and pharmacodynamic properties of once-weekly insulin icodec in individuals with type 2 diabetes. <i>Diabetes, obesity &amp; metabolism</i> 25(12) 3716–3723. DOI:<a href=&quot;https://doi.org/10.1111/dom.15266&quot;>10.1111/dom.15266</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/37694740/&quot;>https://pubmed.ncbi.nlm.nih.gov/37694740</a></p></li><li><p>Haahr, H, et al., &amp; Ignatenko, S (2024). The Effect of Various Degrees of Renal or Hepatic Impairment on the Pharmacokinetic Properties of Once-Weekly Insulin Icodec. <i>Clinical pharmacokinetics</i> 63(6) 819–830. DOI:<a href=&quot;https://doi.org/10.1007/s40262-024-01375-2&quot;>10.1007/s40262-024-01375-2</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/38722461/&quot;>https://pubmed.ncbi.nlm.nih.gov/38722461</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end InsulinIcodec;
